High-throughput screening cytometry provides comprehensive assessment of mesenchymal stem cell identity and differentiation

Accurate identification of mesenchymal stem cells (MSCs) is critical in cell therapy to ensure therapeutic efficacy, safety, and compliance with regulatory standards. Discover how cytometry can detect shifts in marker expression, such as decreased MSC-positive markers alongside increased CD34 and CD45 during differentiation, and the rise in ALPL and FABP4 as indicators of osteoblastic and adipogenic maturation, respectively.

By providing rapid, multiparametric analysis, high-throughput screening cytometry enhances workflow efficiency and data reliability, supporting the advancement of MSC applications in regenerative medicine.